A David Burden Selected Research

Inflammation (Inflammations)

1/2018	MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2.
1/2017	Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2.
11/2016	AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A David Burden Research Topics

Disease

33	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 10/2004
3	Skin Diseases (Skin Disease) 04/2021 - 03/2012
3	Inflammation (Inflammations) 01/2018 - 11/2016
2	Infections 12/2021 - 01/2016
1	Pain (Aches) 02/2024
1	Chronic Disease (Chronic Diseases) 02/2024
1	Fatigue 02/2024
1	Injection Site Reaction 10/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Atopic Dermatitis (Atopic Eczema) 10/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Psoriatic Arthritis 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Necrosis 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2012
1	Nephrogenic Fibrosing Dermopathy 09/2010
1	Crohn Disease (Crohn's Disease) 09/2007

Drug/Important Bio-Agent (IBA)

7	spesolimabIBA 02/2024 - 01/2021
5	Adalimumab (Humira)FDA Link 01/2023 - 01/2016
4	Ustekinumab (CNTO 1275)FDA Link 11/2020 - 01/2018
4	HLA-C Antigens (HLA-C)IBA 01/2019 - 10/2004
3	Monoclonal AntibodiesIBA 10/2023 - 05/2019
2	Peroxidase (Myeloperoxidase)IBA 04/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2019
2	Etanercept (Enbrel)FDA Link 01/2018 - 01/2016
2	Chemokine Receptor D6IBA 01/2018 - 01/2017
2	CC ChemokinesIBA 01/2018 - 01/2017
2	Chemokine ReceptorsIBA 01/2018 - 01/2017
2	ChemokinesIBA 01/2018 - 01/2017
2	CytokinesIBA 11/2016 - 01/2016
1	InterleukinsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 10/2022
1	ConnexinsIBA 06/2021
1	AntibodiesIBA 11/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2020
1	Prostaglandins AIBA 11/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2019
1	secukinumabIBA 05/2019
1	Interleukin-17 (Interleukin 17)IBA 05/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Imiquimod (Aldara)FDA LinkGeneric 01/2017
1	Interleukin-1 (Interleukin 1)IBA 11/2016
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2016
1	RetinoidsIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2014
1	Toll-Like Receptor 3IBA 05/2014
1	HLA-C*06 antigenIBA 05/2011
1	GadoliniumIBA 09/2010
1	Contrast MediaIBA 09/2010
1	calcipotriene (calcipotriol)FDA LinkGeneric 09/2008
1	Betamethasone (Celestone)FDA Link 09/2008
1	N 556IBA 09/2008
1	LigandsIBA 09/2007
1	Interleukin-23 (Interleukin 23)IBA 09/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2005

Therapy/Procedure

8	Biological Therapy 09/2023 - 11/2015
4	Therapeutics 02/2024 - 12/2015
1	Phototherapy (Light Therapy) 01/2016
1	Precision Medicine 03/2012